<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Progestogen for treating threatened miscarriage - Wahabi, HA - 2018 | Cochrane Library</title> <meta content="Progestogen for treating threatened miscarriage - Wahabi, HA - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005943.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Progestogen for treating threatened miscarriage - Wahabi, HA - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005943.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005943.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Progestogen for treating threatened miscarriage" name="citation_title"/> <meta content="Hayfaa A Wahabi" name="citation_author"/> <meta content="King Saud University" name="citation_author_institution"/> <meta content="umlena@yahoo.com" name="citation_author_email"/> <meta content="Amel A Fayed" name="citation_author"/> <meta content="Princess Nourah Bint Abdulrahman University" name="citation_author_institution"/> <meta content="Samia A Esmaeil" name="citation_author"/> <meta content="King Saud University" name="citation_author_institution"/> <meta content="Khawater Hassan Bahkali" name="citation_author"/> <meta content="King Saud University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD005943.pub5" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/08/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005943.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005943.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005943.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Abortion, Spontaneous [epidemiology]; Abortion, Threatened [*drug therapy]; Administration, Intravaginal; Congenital Abnormalities [epidemiology]; Premature Birth [drug therapy, epidemiology, prevention &amp; control]; Progestins [adverse effects, *therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005943.pub5&amp;doi=10.1002/14651858.CD005943.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="gpg7sF9V";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005943\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005943\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ms","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005943.pub5",title:"Progestogen for treating threatened miscarriage",firstPublishedDate:"Aug 6, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=gpg7sF9V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005943.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005943.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005943.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005943.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005943.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005943.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005943.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005943.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005943.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005943.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>17084 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005943.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-sec-0109"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-sec-0103"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/appendices#CD005943-sec-0114"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/table_n/CD005943StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/table_n/CD005943StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Progestogen for treating threatened miscarriage</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/information#CD005943-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Hayfaa A Wahabi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/information#CD005943-cr-0003">Amel A Fayed</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/information#CD005943-cr-0004">Samia A Esmaeil</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005943.pub5/information#CD005943-cr-0005">Khawater Hassan Bahkali</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/information/en#CD005943-sec-0119">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 August 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005943.pub5">https://doi.org/10.1002/14651858.CD005943.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005943-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005943-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005943-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005943-abs-0007">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005943-abs-0001" lang="en"> <section id="CD005943-sec-0001"> <h3 class="title" id="CD005943-sec-0001">Background</h3> <p>Miscarriage is a common complication encountered during pregnancy. It is defined as spontaneous pregnancy loss before 20 weeks' gestation. Progesterone's physiological role is to prepare the uterus for the implantation of the embryo, enhance uterine quiescence and suppress uterine contractions, hence, it may play a role in preventing rejection of the embryo. Inadequate secretion of progesterone in early pregnancy has been linked to the aetiology of miscarriage and progesterone supplementation has been used as a treatment for threatened miscarriage to prevent spontaneous pregnancy loss. This update of the Cochrane Review first published in 2007, and previously updated in 2011, investigates the evidence base for this practice. </p> </section> <section id="CD005943-sec-0002"> <h3 class="title" id="CD005943-sec-0002">Objectives</h3> <p>To determine the efficacy and the safety of progestogens in the treatment of threatened miscarriage. </p> </section> <section id="CD005943-sec-0003"> <h3 class="title" id="CD005943-sec-0003">Search methods</h3> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register, <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (8 August 2017) and reference lists of retrieved trials. </p> </section> <section id="CD005943-sec-0004"> <h3 class="title" id="CD005943-sec-0004">Selection criteria</h3> <p>Randomised, quasi‐randomised or cluster‐randomised controlled trials, that compared progestogen with placebo, no treatment or any other treatment for the treatment of threatened miscarriage in women carrying singleton pregnancy. </p> </section> <section id="CD005943-sec-0005"> <h3 class="title" id="CD005943-sec-0005">Data collection and analysis</h3> <p>At least two review authors assessed the trials for inclusion in the review, assessed trial quality and extracted the data and graded the body of evidence. </p> </section> <section id="CD005943-sec-0006"> <h3 class="title" id="CD005943-sec-0006">Main results</h3> <p>We included seven trials (involving 696 participants) in this update of the review. The included trials were conducted in different countries, covering the full spectrum of the World Bank's economic classification, which enhances the applicability of evidence drawn from this review. Two trials were conducted in Germany and Italy which are high‐income countries, while four trials were conducted in upper‐middle income countries; two in Iran, one in Malaysia and the fourth in Turkey, and the seventh trial was conducted in Jordan, which is a lower‐middle income country. In six trials all the participants met the inclusion criteria and in the seventh study, we included in the meta‐analysis only the subgroup of participants who met the inclusion criteria. We assessed the body of evidence for the main outcomes using the GRADE tool and the quality of the evidence ranged from very low to moderate. Downgrading of evidence was based on the high risk of bias in six of the seven included trials and a small number of events and wide confidence intervals for some outcomes. </p> <p>Treatment of miscarriage with progestogens compared to placebo or no treatment probably reduces the risk of miscarriage; (risk ratio (RR) 0.64, 95% confidence interval (CI) 0.47 to 0.87; 7 trials; 696 women; moderate‐quality evidence). Treatment with oral progestogen compared to no treatment also probably reduces the miscarriage rate (RR 0.57, 95% CI 0.38 to 0.85; 3 trials; 408 women; moderate‐quality evidence). However treatment with vaginal progesterone compared to placebo, probably has little or no effect in reducing the miscarriage rate (RR 0.75, 95% CI 0.47 to 1.21; 4 trials; 288 women; moderate‐quality evidence). The subgroup interaction test indicated no difference according to route of administration between the oral and vaginal subgroups of progesterone. </p> <p>Treatment of miscarriage with the use of progestogens compared to placebo or no treatment may have little or no effect in reducing the rate of preterm birth (RR 0.86, 95% CI 0.52 to 1.44; 5 trials; 588 women; low‐quality evidence). </p> <p>We are uncertain if treatment of threatened miscarriage with progestogens compared to placebo or no treatment has any effect on the rate of congenital abnormalities because the quality of the evidence is very low (RR 0.70, 95% CI 0.10 to 4.82; 2 trials; 337 infants; very‐low quality evidence). </p> </section> <section id="CD005943-sec-0007"> <h3 class="title" id="CD005943-sec-0007">Authors' conclusions</h3> <p>The results of this Cochrane Review suggest that progestogens are probably effective in the treatment of threatened miscarriage but may have little or no effect in the rate of preterm birth. The evidence on congenital abnormalities is uncertain, because the quality of the evidence for this outcome was based on only two small trials with very few events and was found to be of very low quality. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005943-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005943-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005943-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005943-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD005943-abs-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD005943-abs-0003">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005943-abs-0002" lang="en"> <h3>Progestogen for treating threatened miscarriage</h3> <p><b>What is the issue?</b> </p> <p>Spontaneous miscarriage occurs in about 15% to 20% of pregnancies. Threatened miscarriage occurs when a mother might be losing her baby at less than 20 weeks' gestation. The symptoms of threatened miscarriage are vaginal bleeding, with or without abdominal pain, while the cervix of the womb is closed and the baby inside the womb is alive. Progesterone is a hormone that is known to prepare the uterus for implantation of the fertilized egg and suppress uterine contractions until term. Medications that mimic the action of progesterone are known as progestogens. Treatment with progestogens may be effective in reducing the rate of miscarriage in women who have threatened miscarriage. This Cochrane Review examines whether progestogens could reduce miscarriage for women with threatened miscarriage, and also addresses the safety of these medications for mother and baby. </p> <p><b>Why is this important?</b> </p> <p>We were interested to investigate if progestogens are effective and safe in the treatment of threatened miscarriage, which may increase the women's chances of having a successful pregnancy and a live birth. </p> <p><b>What evidence did we find?</b> </p> <p>In this review of the literature, up to August 2017, we identified seven randomised trials involving 696 women that compared the use of progestogens in the treatment of threatened miscarriage with either placebo or no treatment. We found that the use of a progestogen probably reduces the rate of spontaneous miscarriage and this was supported by moderate‐quality evidence. Five trials, involving 588 women, reported on the effectiveness of progestogens given for threatened miscarriage in reducing the rate of preterm delivery and showed little or no effect, with low‐quality evidence. Two trials, involving 337 women, reported on the effect of treatment with progestogens given for threatened miscarriage on the rate of occurrence of congenital abnormalities in the newborns. The evidence on congenital abnormalities is uncertain, because the quality of the evidence for this outcome was based on only two small trials with very few events and was found to be of very low quality. </p> <p><b>What does this mean?</b> </p> <p>The evidence suggests that progesterone probably reduces the rate of spontaneous miscarriage but may make little or no difference to the number of preterm deliveries. The evidence for congenital abnormalities is uncertain because the quality of the evidence for this outcome was based on only two small trials with very few events and was found to be of very low quality. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005943-sec-0109" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005943-sec-0109"></div> <h3 class="title" id="CD005943-sec-0110">Implications for practice</h3> <section id="CD005943-sec-0110"> <p>The results of this review suggest that progestogens are probably effective in the treatment of threatened miscarriage but may have little or no effect in the rate of preterm birth. The evidence on congenital abnormalities is uncertain, because the quality of the evidence for this outcome was based on only two small trials with very few events and was found to be of very low quality. </p> </section> <h3 class="title" id="CD005943-sec-0111">Implications for research</h3> <section id="CD005943-sec-0111"> <p>Further research could investigate the effectiveness and safety of progestogens in the treatment of threatened miscarriage by conducting methodologically sound, randomised trials, with special focus on the type of progestogen and the route of administration. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005943-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005943-sec-0008"></div> <div class="table" id="CD005943-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Progesterone compared to placebo or no treatment for treating threatened miscarriage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Progesterone compared to placebo or no treatment for treating threatened miscarriage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population</b> : women with threatened miscarriage<br/> <b>Setting:</b> two in high‐income countries (Germany and Italy), four in upper‐middle income countries (two in Iran, one in Malaysia and one in Turkey) and one in lower‐income country (Jordan). All in hospitals (university or women's) or medical centres<br/> <b>Intervention:</b> progesterone<br/> <b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with progesterone</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.64<br/> (0.47 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>696<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>242 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>138 per 1000<br/> (102 to 189) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Preterm birth</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.86<br/> (0.52 to 1.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>588<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>84 per 1000<br/> (49 to 142) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Congential abnormalities</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.70<br/> (0.10 to 4.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>337<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (1 to 62) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Random sequence generation and/or allocation concealment had a high or unclear risk of bias in the majority of the trials (methodological quality of trials) (‐1).<br/> <sup>2</sup>Wide confidence interval crossing the no effect line (imprecision) (‐1).<br/> <sup>3</sup>A small number of events (‐1). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005943-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005943-sec-0009"></div> <section id="CD005943-sec-0010"> <h3 class="title" id="CD005943-sec-0010">Description of the condition</h3> <p>"Miscarriage is pregnancy loss before 20 weeks' gestation based on the first day of the last menstrual period or, if gestation age is unknown, it is the loss of an embryo or a fetus of less than 400 g" (<a href="./references#CD005943-bbs2-0112" title="Zegers‐HochschildF , AdamsonGD , DeMJ , IshiharaO , MansourR , NygrenK , et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology. Fertility and Sterility2009;92:1520‐4. ">Zegers‐Hochschild 2009</a>). Threatened miscarriage is manifested by vaginal bleeding, with or without abdominal pain, while the cervix is closed and the fetus is viable and inside the uterine cavity (<a href="./references#CD005943-bbs2-0067" title="CunninghamFG . Section IX. Reproductive success and failure. Williams Obstetrics. 21st Edition. New York: McGraw‐Hill, 2001. ">Cunningham 2001a</a>). Once the cervix begins to dilate, miscarriage and pregnancy loss are inevitable. When the fetus is non‐viable and the cervix is closed, this is known as missed miscarriage or missed abortion (<a href="./references#CD005943-bbs2-0067" title="CunninghamFG . Section IX. Reproductive success and failure. Williams Obstetrics. 21st Edition. New York: McGraw‐Hill, 2001. ">Cunningham 2001a</a>). The presence of a short cervix or funnelling of the internal cervical os in the gestation period between 16 and 24 weeks has been found to indicate increased risk or threat to miscarriage (<a href="./references#CD005943-bbs2-0096" title="OwenJ , YostN , BerghellaV , MacPhersonC , SwainM , DildyGA3rd , et al. Can shortened midtrimester cervical length predict very early spontaneous preterm birth?. American Journal of Obstetrics and Gynecology2004;191(1):298‐303. ">Owen 2004</a>; <a href="./references#CD005943-bbs2-0099" title="RustOA , AtlasRO , KimmelS , RobertsWE , HessLW . Does the presence of a funnel increase the risk of adverse perinatal outcome in a patient with a short cervix?. American Journal of Obstetrics and Gynecology2005;192(4):1060‐6. ">Rust 2005</a>). </p> <p>Miscarriage is a common complication of pregnancy occurring in 15% to 20% of all clinically recognised pregnancies (<a href="./references#CD005943-bbs2-0062" title="BlohmF , FridenB , MilsomI . A prospective longitudinal population‐based study of clinical miscarriage in an urban Swedish population. BJOG: an international journal of obstetrics and gynaecology2008;115:176‐82. ">Blohm 2008</a>; <a href="./references#CD005943-bbs2-0065" title="CohainJS , BuxbaumRE , MankutaD . Spontaneous first trimester miscarriage rates per woman among parous women with 1 or more pregnancies of 24 weeks or more. BMC Pregnancy and Childbirth2017;17(1):437. ">Cohain 2017</a>). As many as 50% of the miscarried fetuses and embryos have normal chromosomes (<a href="./references#CD005943-bbs2-0105" title="SuzumoriN , Sugiura‐OgasawaraM . Genetic factors as a cause of miscarriage. Current Medicinal Chemistry2010;17:3431‐7. ">Suzumori 2010</a>; <a href="./references#CD005943-bbs2-0110" title="VorsanovaSG , KolotiiAD , IourovIY , MonakhovVV , KirillovaEA , SolovievIV , et al. Evidence for high frequency of chromosomal mosaicism in spontaneous abortions revealed by interphase FISH analysis. Journal of Histochemistry and Cytochemistry2005;53:375‐80. ">Vorsanova 2005</a>). In many cases, the cause of miscarriage cannot be identified, however, among the recognised risk factors of miscarriage are maternal age over 34 years and paternal age over 40 years (<a href="./references#CD005943-bbs2-0070" title="De LaRochebrochardE , ThonneauP . Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study. Human Reproduction2002;17:1649‐56. ">De La Rochebrochard 2002</a>), previous history of two or more miscarriages (<a href="./references#CD005943-bbs2-0104" title="Sugiura‐OgasawaraM , OzakiY , KitaoriT , SuzumoriN , ObayashiS , SuzukiS . Live birth rate according to maternal age and previous number of recurrent miscarriages. American Journal of Reproductive Immunology2009;62:314‐9. ">Sugiura‐Ogasawara 2009</a>), and maternal autoimmune factors such as phospholipids antibodies (<a href="./references#CD005943-bbs2-0064" title="CheckJH . A practical approach to the prevention of miscarriage: part 5‐‐antiphospholipid syndrome as a cause of spontaneous abortion. Clinical and Experimental Obstetrics and Gynecology2011;38:5‐9. ">Check 2011</a>). In addition, many modifiable risk factors were recognised including maternal obesity (<a href="./references#CD005943-bbs2-0079" title="HahnKA , HatchEE , RothmanKJ , MikkelsenEM , BroglySB , SørensenHT , et al. Body size and risk of spontaneous abortion among Danish pregnancy planners. Paediatric and Perinatal Epidemiology2014;28(5):412‐23. ">Hahn 2014</a>), maternal infection such as genital herpes simplex, HIV‐1 and vaginal colonisation of group B streptococci (<a href="./references#CD005943-bbs2-0092" title="NigroG , MazzoccoM , MattiaE , DiRenzoGC , CartaG , AnceschiMM . Role of the infections in recurrent spontaneous abortion. Journal of Maternal Fetal Neonatal Medicine2011;24:983‐9. ">Nigro 2011</a>; <a href="./references#CD005943-bbs2-0098" title="RocchettiTT , MarconiC , RallVL , BorgesVT , CorrenteJE , DaSilvaMG . Group B streptococci colonization in pregnant women: risk factors and evaluation of the vaginal flora. Archives of Gynecology and Obstetrics2011;283:717‐21. ">Rocchetti 2011</a>; <a href="./references#CD005943-bbs2-0109" title="TemmermanM , LopitaMI , SanghviHC , SineiSK , PlummerFA , PiotP . The role of maternal syphilis, gonorrhoea and HIV‐1 infection in spontaneous abortion. International Journal of Sexually Transmitted Diseases and AIDS1992;3:418‐22. ">Temmerman 1992</a>). Maternal endocrine abnormalities such as uncontrolled diabetes mellitus (<a href="./references#CD005943-bbs2-0075" title="GalindoA , BurguilloAG , AzrielS , Fuente P deL . Outcome of fetuses in women with pregestational diabetes mellitus. Journal of Perinatal Medicine2006;34(4):323‐31. ">Galindo 2006</a>), polycystic ovary syndrome (<a href="./references#CD005943-bbs2-0061" title="ArredondoF , NobleLS . Endocrinology of recurrent pregnancy loss. Seminars in Reproductive Medicine2006;24:33‐9. ">Arredondo 2006</a>) and insufficient production of progesterone are other known risk factors. Progesterone insufficiency is due to corpus luteum (CL) deficiency, which is a group of cells in the ovary that are formed after the release of the ovum (<a href="./references#CD005943-bbs2-0068" title="CunninghamFG , editor(s) . Physiology of pregnancy. Williams Obstetrics. 21st Edition. New York: McGraw‐Hill, 2001. ">Cunningham 2001b</a>). The main function of the CL is to produce sufficient progesterone to prepare and support the lining of the uterus and facilitate implantation of the ovum (<a href="./references#CD005943-bbs2-0068" title="CunninghamFG , editor(s) . Physiology of pregnancy. Williams Obstetrics. 21st Edition. New York: McGraw‐Hill, 2001. ">Cunningham 2001b</a>). It is suggested that progesterone deficiency in early pregnancy may be an aetiological factor for miscarriage, hence, treatment with progesterone may prevent miscarriage. However the evidence support for the effectiveness and safety of such treatment is uncertain based on the results of recently published trials (<a href="./references#CD005943-bbs2-0066" title="CoomarasamyA , WilliamsH , TruchanowiczE , SeedPT , SmallR , QuenbyS , et al. A randomized trial of progesterone in women with recurrent miscarriages. New England Journal of Medicine2015;373(22):2141‐8. ">Coomarasamy 2015</a>; <a href="./references#CD005943-bbs2-0100" title="SacconeG , SchoenC , FranasiakJM , ScottRTJr , BerghellaV . Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta‐analysis of randomized, controlled trials. Fertility and Sterility2017;107(2):430‐8. ">Saccone 2017</a>). </p> </section> <section id="CD005943-sec-0011"> <h3 class="title" id="CD005943-sec-0011">Description of the intervention</h3> <p>Progestogens are a group of hormones that bind to the progesterone receptors; they include both the natural female sex hormone progesterone and the synthetic forms. Medications that mimic the action of progesterone are known as progestational agents. Progesterone and progestational agents are known as progestogens. Progesterone is secreted during early pregnancy from the ovary by CL (<a href="./references#CD005943-bbs2-0068" title="CunninghamFG , editor(s) . Physiology of pregnancy. Williams Obstetrics. 21st Edition. New York: McGraw‐Hill, 2001. ">Cunningham 2001b</a>). It is an essential hormone for the establishment and maintenance of pregnancy. Progestogens can be given to women with threatened miscarriage orally, as intramuscular injection or in the form of vaginal suppositories. Due to the wide range of doses, preparations and types of progestogens used for the treatment of threatened miscarriage (<a href="./references#CD005943-bbs2-0063" title="CarpH . A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecological Endocrinology2012;28(12):983‐90. ">Carp 2012</a>; <a href="./references#CD005943-bbs2-0091" title="MirzaFG , PatkiA , Pexman‐FiethC . Dydrogesterone use in early pregnancy. Gynecological Endocrinology2016;32(2):97‐106. ">Mirza 2016</a>), it is uncertain what is the best type, dose and route of administration for the treatment of threatened miscarriage. </p> </section> <section id="CD005943-sec-0012"> <h3 class="title" id="CD005943-sec-0012">How the intervention might work</h3> <p>Progesterone induces secretory changes in the lining of the uterus, which are important for implantation of the fertilised ovum (<a href="./references#CD005943-bbs2-0085" title="JinS , LiSW , LongJ , LiL , TanZJ . The role of progesterone in human early pregnancy is mediated by insulin‐like growth factors binding protein1‐3. Sichuan Da Xue Xue Bao Yi Xue Ban2006;37:399‐403. ">Jin 2006</a>). In addition, it modulates the immune response of the mother to prevent rejection of the embryo through a protein called progesterone induced blocking factor (PIBF), which is produced by the lymphocytes (white blood cells) of the pregnant woman (<a href="./references#CD005943-bbs2-0108" title="Szekeres‐BarthoJ , PolgarB . PIBF: the double edged sword. Pregnancy and tumor. American Journal of Reproductive Immunology2010;64(2):77‐86. ">Szekeres‐Bartho 2010</a>), and it enhances uterine quiescence and suppresses uterine contractions (<a href="./references#CD005943-bbs2-0106" title="Szekeres‐BarthoJ , WilczynskiJR , BastaP , KalinkaJ . Role of progesterone and progestin therapy in threatened abortion and preterm labour. Frontiers in Bioscience2008;13:1981‐90. ">Szekeres‐Bartho 2008</a>; <a href="./references#CD005943-bbs2-0107" title="Szekeres‐BarthoJ . Progesterone‐mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage. Immunotherapy2009;1:873‐82. ">Szekeres‐Bartho 2009</a>). Low progesterone levels have been linked to increased risk of first trimester miscarriage (<a href="./references#CD005943-bbs2-0095" title="OsmanağaoğluMA , ErdoğanI , EminağaoğluS , KarahanSC , OzgünS , CanG , et al. The diagnostic value of beta‐human chorionic gonadotropin, progesterone, CA125 in the prediction of abortions. Journal of Obstetrics and Gynaecology2010;30:288‐93. ">Osmanağaoğlu 2010</a>). </p> <p>Owing to the documented physiological role of progesterone in maintaining pregnancy, it has been used to treat women with threatened miscarriage and presumed progesterone deficiency to improve expectations for continuity of pregnancy (<a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>). The therapeutic value of progesterone in preventing or treating threatened miscarriage has not been established (<a href="./references#CD005943-bbs2-0086" title="KalinkaJ , Szekeres‐BarthoJ . The impact of dydrogesterone supplementation on hormonal profile and progesterone‐induced blocking factor concentrations in women with threatened abortion. American Journal of Reproductive Immunology2005;53:166‐71. ">Kalinka 2005</a>), although more recent evidence suggests that it may be effective in preventing miscarriage in women with a history of recurrent miscarriage of unclear etiology (<a href="./references#CD005943-bbs2-0078" title="HaasDM , HathawayTJ , RamseyPS . Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database of Systematic Reviews2018, Issue [in press]. ">Haas 2018</a>). This might be due to the poor designs of the trials done to evaluate its effectiveness (<a href="./references#CD005943-bbs2-0086" title="KalinkaJ , Szekeres‐BarthoJ . The impact of dydrogesterone supplementation on hormonal profile and progesterone‐induced blocking factor concentrations in women with threatened abortion. American Journal of Reproductive Immunology2005;53:166‐71. ">Kalinka 2005</a>), and the inclusion of women in these trials with different aetiologies for threatened miscarriage. </p> </section> <section id="CD005943-sec-0013"> <h3 class="title" id="CD005943-sec-0013">Why it is important to do this review</h3> <p>Miscarriage is associated with considerable physical and psychological morbidity. Women who had threatened miscarriage were found to have increased rate of antepartum haemorrhage, pre‐labour rupture of the membranes, preterm delivery, and intrauterine growth restriction when compared with women who did not have threatened miscarriage (<a href="./references#CD005943-bbs2-0101" title="SaraswatL , BhattacharyaS , MaheshwariA , BhattacharyaS . Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG: an international journal of obstetrics and gynaecology2010;117:245‐57. ">Saraswat 2010</a>). The emotional response to miscarriage can be profound; it includes depression, sleep disturbance, anger, and marital disturbances (<a href="./references#CD005943-bbs2-0090" title="MarcinkoVM , MarcinkoD , DordevicV , OreskovicS . Anxiety and depression in pregnant women with previous history of spontaneous abortion. Collegium Antropologicum2011;35 Suppl 1:225‐8. ">Marcinko 2011</a>). The introduction of ultrasound scans in the management of bleeding in early pregnancy has improved the diagnosis by rapid confirmation of viability and has improved the management by introducing prognostic factors such as fetal bradycardia and discrepancy between gestational age and crown‐to‐rump length (<a href="./references#CD005943-bbs2-0071" title="DedeFS , UlucayU , KoseMF , DedeH , DilbazS . Fetal loss in threatened abortion after demonstration of fetal cardiac activity in a low socioeconomic population. Journal of Obstetrics and Gynaecology2010;30:622‐5. ">Dede 2010</a>; <a href="./references#CD005943-bbs2-0089" title="MakrydimasG , SebireNJ , LolisD , VlassisN , NicolaidesKH . Fetal loss following ultrasound diagnosis of a live fetus at 6‐10 weeks of gestation. Ultrasound in Obstetrics and Gynecology2003;22:368‐72. ">Makrydimas 2003</a>). This has rationalised the management of threatened miscarriage, as attempts to maintain a pregnancy are likely to be effective only if the fetus is viable and has no chromosomal abnormalities (<a href="./references#CD005943-bbs2-0088" title="LedeR , DuleyL . Uterine muscle relaxant drugs for threatened miscarriage. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD002857.pub2] ">Lede 2005</a>). </p> <p>The importance of progesterone on the maintenance of pregnancy was demonstrated by the successful use of progesterone antagonists, such as mifepristone (RU 486) in the elective induction of abortion (<a href="./references#CD005943-bbs2-0069" title="DabashR , ChelliH , HajriS , ShochetT , RaghavanS , WinikoffB . A double‐blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14‐21 weeks of pregnancy. International Journal of Gynecology &amp; Obstetrics2015;130(1):40‐4. ">Dabash 2015</a>). In a recently published systematic review vaginally administered progesterone was more effective in the prevention of preterm birth compared to the injectable progesterone (<a href="./references#CD005943-bbs2-0094" title="OlerE , EkeAC , HessonA . Meta‐analysis of randomized controlled trials comparing 17α‐hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery. International Journal of Gynecology &amp; Obstetrics2017;138(1):12‐6. ">Oler 2017</a>). This raised the question about the importance of the route of administration and the type of progestogen used to prevent preterm labour (<a href="./references#CD005943-bbs2-0073" title="DiRenzoGC , RosatiA , MatteiA , GojinicM , GerliS . The changing role of progesterone in preterm labour. BJOG: an international journal of obstetrics and gynaecology2005;112 Suppl 1:57‐60. ">Di Renzo 2005</a>). These same questions might apply to the use of progestogens in the treatment of threatened miscarriage. </p> <p>In earlier reports progestogen therapy has been linked to the development of hypospadias (deformity of the penis) in the male fetus (<a href="./references#CD005943-bbs2-0102" title="SilverRI , RodriguezR , ChangTS , GearhartJP . In vitro fertilization is associated with an increased risk of hypospadias. Journal of Urology1999;161(6):1954‐7. ">Silver 1999</a>); however, recent reports did not show an increase in rate of hypospadias in infants of mothers who received progestogens in early pregnancy (<a href="./references#CD005943-bbs2-0087" title="KällénB , FinnströmO , LindamA , NilssonE , NygrenKG , OtterbladPO . Congenital malformations in infants born after in vitro fertilization in Sweden. Birth Defects Research. Part A Clinical and Molecular Teratology2010;88:137‐43. ">Källén 2010</a>). </p> <p>The aim of this review is to study all the available data on the effectiveness of administration of progestogens for the treatment of threatened miscarriage. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005943-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005943-sec-0014"></div> <p>To determine the efficacy and the safety of progestogens in the treatment of threatened miscarriage. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005943-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005943-sec-0015"></div> <section id="CD005943-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005943-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised, quasi‐randomised or cluster‐randomised controlled trials, that assessed the effectiveness and safety of progestogens in the treatment of threatened miscarriage compared to placebo, no treatment or other intervention, if viability of the embryo or the fetus was confirmed before the commencement of treatment. </p> </section> <section id="CD005943-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included pregnant women, with threatened miscarriage at or less than 23 weeks, with singleton embryo or fetus, and who had a confirmed viable pregnancy. Fetal viability was to ensure that we excluded from this review trials that included women with bleeding in early pregnancy due to missed miscarriage. We have placed no restriction on the age of the woman or past obstetric history. </p> </section> <section id="CD005943-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included any type of progestogens, natural or synthetic, used in the treatment of threatened miscarriage regardless of the dose, duration or route of administration compared with placebo, no treatment or other intervention. </p> </section> <section id="CD005943-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD005943-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD005943-list-0001"> <li> <p>Miscarriage</p> </li> </ol> </p> </section> <section id="CD005943-sec-0022"> <h5 class="title">Secondary outcomes</h5> <section id="CD005943-sec-0023"> <h6 class="title">Mother</h6> <p> <ol id="CD005943-list-0002"> <li> <p>Pain relief (as defined by the study authors)</p> </li> <li> <p>Thromboembolism</p> </li> <li> <p>Preterm birth</p> </li> <li> <p>Depression (as defined by the study authors)</p> </li> <li> <p>Any other adverse outcomes that were reported (pregnancy‐induced hypertension; antepartum haemorrhage) </p> </li> </ol> </p> </section> <section id="CD005943-sec-0024"> <h6 class="title">Child</h6> <p> <ol id="CD005943-list-0003"> <li> <p>Preterm birth</p> </li> <li> <p>Stillbirth</p> </li> <li> <p>Neonatal death</p> </li> <li> <p>Congenital abnormalities, including genital malformations</p> </li> <li> <p>Any other adverse neonatal outcomes that were reported (intrauterine growth restriction; respiratory distress syndrome) </p> </li> <li> <p>Low birthweight (not prespecified)</p> </li> <li> <p>Birthweight (not prespecified)</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD005943-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD005943-sec-0026"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (8 August 2017) </p> <p>The Register is a database containing over 23,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth</a> in the Cochrane Library and select the ‘<i><b>Specialized Register</b> </i> ’ section from the options on the left side of the screen. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD005943-list-0004"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Two people screen the search results and review the full text of all relevant trial reports identified through the searching activities described above. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set that has been fully accounted for in the relevant review sections (<a href="./references#CD005943-bbs1-0001" title="">Included studies</a>; <a href="./references#CD005943-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD005943-bbs1-0003" title="">Studies awaiting classification</a>; <a href="./references#CD005943-bbs1-0004" title="">Ongoing studies</a>). </p> <p>In addition, we searched <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) for unpublished, planned and ongoing trial reports (8 August 2017) using the search terms given in <a href="./appendices#CD005943-sec-0115">Appendix 1</a>. </p> </section> <section id="CD005943-sec-0027"> <h4 class="title">Searching other resources</h4> <p>We scanned bibliographies of identified papers.</p> <p>We did not apply any language restrictions.</p> </section> </section> <section id="CD005943-sec-0028"> <h3 class="title" id="CD005943-sec-0028">Data collection and analysis</h3> <p>We have outlined the methods of data collection and analysis that we used to assess <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a> and <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a> in the previous version of this review, <a href="./references#CD005943-bbs2-0113" title="WahabiHA , FayedAA , EsmaeilSA , Al ZeidanRA . Progestogen for treating threatened miscarriage. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD005943.pub4] ">Wahabi 2011</a>. </p> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD005943-sec-0029"> <h4 class="title">Selection of studies</h4> <p>Three review authors independently assessed for inclusion all the potential trials we identified as a result of the search strategy. We resolved any disagreement through discussion. </p> </section> <section id="CD005943-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>For methods used in the previous version of this review, see <a href="./references#CD005943-bbs2-0113" title="WahabiHA , FayedAA , EsmaeilSA , Al ZeidanRA . Progestogen for treating threatened miscarriage. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD005943.pub4] ">Wahabi 2011</a>. </p> <p>For this update, we used the following methods for assessing the 29 reports that the Information Specialist identified as a result of the updated search. </p> </section> <section id="CD005943-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The four review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005943-bbs2-0083" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). We resolved any disagreement by discussion. </p> <section id="CD005943-sec-0032"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>For each included study we assessed the method as being at:</p> <p> <ul id="CD005943-list-0005"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD005943-sec-0033"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>For each included study we described the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as being at:</p> <p> <ul id="CD005943-list-0006"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD005943-sec-0034"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>For each included study we described the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that trials were at low risk of bias if they were blinded, or if we judged that the lack of blinding was unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as being at:</p> <p> <ul id="CD005943-list-0007"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD005943-sec-0035"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>For each included study we described the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as being at:</p> <p> <ul id="CD005943-list-0008"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD005943-sec-0036"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>For each included study, and for each outcome or class of outcomes, we described the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses that we undertook. </p> <p>We assessed methods as being at:</p> <p> <ul id="CD005943-list-0009"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> <p>We excluded trials where more than 20% of participants were lost to follow‐up.</p> </section> <section id="CD005943-sec-0037"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>For each included study we described how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as being at:</p> <p> <ul id="CD005943-list-0010"> <li> <p>low risk of bias (where it was clear that all of the study’s prespecified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s prespecified outcomes were reported; one or more reported primary outcomes were not prespecified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD005943-sec-0038"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>For each included study we described any important concerns we had about other possible sources of bias. </p> </section> <section id="CD005943-sec-0039"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether trials were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005943-bbs2-0083" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it was likely to have an impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses (<a href="#CD005943-sec-0051">Sensitivity analysis</a>). </p> </section> <section id="CD005943-sec-0040"> <h5 class="title">Assessment of the quality of the evidence using the GRADE approach</h5> <p>For this update of the review, we used the GRADE approach, as outlined in the GRADE handbook (<a href="./references#CD005943-bbs2-0076" title="Editors: SchünemannH , BrożekJ , GuyattG , OxmanA . Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html. ">GRADE 2013</a>), to assess the quality of the body of evidence relating to the following outcomes for the main comparisons, progesterone versus placebo or no treatment. </p> <p> <ol id="CD005943-list-0011"> <li> <p>Miscarriage</p> </li> <li> <p>Preterm birth</p> </li> <li> <p>Congenital abnormalities</p> </li> </ol> </p> <p>We used the GRADEpro Guideline Development tool (<a href="./references#CD005943-bbs2-0077" title="McMaster University (developed by Evidence Prime). GRADE pro GDT. Version 'date accessed' 12/09/17. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>) to import data from Review Manager 5 (RevMan 5) (<a href="./references#CD005943-bbs2-0097" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) in order to create 'Summary of findings' tables. We produced a summary of the intervention effect and using the GRADE approach, a measure of quality for each of the above outcomes. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD005943-sec-0041"> <h4 class="title">Measures of treatment effect</h4> <section id="CD005943-sec-0042"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we present results as summary risk ratio (RR) with 95% confidence intervals (CIs).  </p> </section> <section id="CD005943-sec-0043"> <h5 class="title">Continuous data</h5> <p>None of the outcomes were reported as continuous data in this update. In future updates, if trials measure outcomes in the same way, we will use the mean difference. We will use the standardised mean difference to combine trials that measure the same outcome, but use different methods<i>.</i> </p> </section> </section> <section id="CD005943-sec-0044"> <h4 class="title">Unit of analysis issues</h4> <section id="CD005943-sec-0045"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐randomised trials for inclusion. If we identify any cluster‐randomised trials in future updates of this review, we will include them in the analyses along with individually randomised trials. We will adjust their sample sizes using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions,</i> using an estimate of the intra‐cluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population (<a href="./references#CD005943-bbs2-0084" title="HigginsJPT , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011c</a>). If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a subgroup analysis to investigate the effects of the randomisation unit. </p> </section> </section> <section id="CD005943-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>For included trials, we noted levels of attrition. For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, that is, we attempted to include all participants randomised to each group in the analyses, and analysed all participants in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD005943-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² (<a href="./references#CD005943-bbs2-0081" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>) and Chi² statistics (<a href="./references#CD005943-bbs2-0072" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). We regarded heterogeneity as substantial if I² was greater than 30% and either Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity.  </p> </section> <section id="CD005943-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates of this review, if there are 10 or more trials in the meta‐analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it (<a href="./references#CD005943-bbs2-0103" title="SterneJAC , EggerM , MoherD (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). </p> </section> <section id="CD005943-sec-0049"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the RevMan 5 software (<a href="./references#CD005943-bbs2-0097" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that trials were estimating the same underlying treatment effect: that is, where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. In future updates, if there is clinical heterogeneity sufficient to expect that the underlying treatment effects would differ between trials, or if we detect substantial statistical heterogeneity, we will use random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials is considered clinically meaningful. We will treat the random‐effects summary as the average range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful we will not combine trials (<a href="./references#CD005943-bbs2-0072" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> <p>If we use random‐effects analyses, we will present the results as the average treatment effect with 95% CIs, and the estimates of Tau² and I². </p> </section> <section id="CD005943-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not identify substantial heterogeneity. However, we carried out the following subgroup analyses for the primary outcome. </p> <p> <ol id="CD005943-list-0012"> <li> <p>Route of administration</p> </li> </ol> </p> <p>If we identify substantial heterogeneity in future updates of this review, we will investigate it using subgroup analyses and sensitivity analyses. We will consider whether an overall summary is meaningful, and if it is, use random‐effects analysis to produce it. We will include the following subgroups, in addition to route of administration. </p> <p> <ol id="CD005943-list-0013"> <li> <p>Type of progestogen</p> </li> <li> <p>Progestogen dose</p> </li> <li> <p>Effect of progestogens in early (no more than 12 weeks) and late (more than 12 weeks) threatened miscarriage </p> </li> </ol> </p> <p>We will restrict subgroup analysis to the primary outcome. We will assess subgroup differences by interaction tests available within RevMan 5 (<a href="./references#CD005943-bbs2-0097" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We will report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value (<a href="./references#CD005943-bbs2-0072" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> </section> <section id="CD005943-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>We included seven trials in this review. All but one were similar in terms of risk of bias. For future updates of this review, we will carry out sensitivity analysis to explore the effect of risk of bias. This will involve analysis based on our 'Risk of bias' judgements for allocation concealment, performance bias and attrition bias. We will compare the results of those trials assessed as being rated 'low' risk of bias for these domains with those rated as 'high' or 'unclear' risk of bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005943-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005943-sec-0052"></div> <section id="CD005943-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD005943-sec-0054"> <h4 class="title">Results of the search</h4> <p>We assessed 29 new trial reports of potential relevance identified by the updated search (see: <a href="#CD005943-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD005943-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Trial flow diagram" data-id="CD005943-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Trial flow diagram</p> </div> </div> </div> </section> <section id="CD005943-sec-0055"> <h4 class="title">Included studies</h4> <section id="CD005943-sec-0056"> <h5 class="title">Trial location</h5> <p>We included seven trials (involving 696 participants) in this update of the review. The included trials were conducted in different countries, covering the full spectrum of the World Bank's economic classification (<a href="./references#CD005943-bbs2-0111" title="WorldBank . World Bank list of economies. iccmoot.com/wp‐content/uploads/2017/07/World‐Bank‐List‐of‐Economies.pdf. ">World Bank 2017</a>), which may enhance the applicability and generalisation of evidence drawn from this review. Two trials were conducted in Germany and Italy (<a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>), which are high‐income countries, while four trials were conducted in upper‐middle income countries; two in Iran (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>), one in Malaysia (<a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>) and the fourth in Turkey (<a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>). The seventh trial was conducted in Jordan (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>), which is a lower‐middle income country. All trials were conducted in hospital settings. </p> </section> <section id="CD005943-sec-0057"> <h5 class="title">Trial design</h5> <p>We included six randomised controlled trials (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>) and one quasi‐randomised controlled trial (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>). </p> </section> <section id="CD005943-sec-0058"> <h5 class="title">Sample size</h5> <p>A total of 696 women were included in this review. The largest trial involved 191 women (<a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>) and the smallest involved 35 women (<a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>). </p> </section> <section id="CD005943-sec-0059"> <h5 class="title">Participants</h5> <p>We included pregnant women, with threatened miscarriage at or less than 23 weeks and who had a confirmed viable pregnancy. Fetal viability was to ensure that we excluded from this review trials that included women with bleeding in early pregnancy due to missed miscarriage. We placed no restriction on the age of the woman or past obstetric history. </p> </section> <section id="CD005943-sec-0060"> <h5 class="title">Type of intervention</h5> <p>The seven included trials compared progestogens to either placebo (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>) or no treatment (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>). Three trials investigated oral progestogen (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>) and four investigated vaginal progesterone (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>). </p> </section> <section id="CD005943-sec-0061"> <h5 class="title">Outcome measure</h5> <section id="CD005943-sec-0062"> <h6 class="title">Primary outcome</h6> <section id="CD005943-sec-0063"> <p><b>Miscarriage</b></p> <p>All the included trials investigated this primary outcome. Three trials investigated oral progestogen (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>), and four trials investigated vaginal progesterone (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>). </p> </section> </section> <section id="CD005943-sec-0064"> <h6 class="title">Secondary outcomes</h6> <section id="CD005943-sec-0065"> <p><b>Pain relief</b></p> <p>Two trials (<a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>) reported pain relief as an outcome of treatment with progesterone. </p> </section> <section id="CD005943-sec-0066"> <p><b>Preterm birth</b></p> <p>Five trials (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>, <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>); with 588 women, reported the effect of oral or vaginal progestogens on preterm birth. </p> </section> <section id="CD005943-sec-0067"> <p><b>Pregnancy‐induced hypertension</b></p> <p>Two trials (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>) reported pregnancy‐induced hypertension as a maternal adverse outcome. </p> </section> <section id="CD005943-sec-0068"> <p><b>Antepartum haemorrhage</b></p> <p>Two trials (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>) reported antepartum haemorrhage as a maternal adverse outcome. </p> </section> <section id="CD005943-sec-0069"> <p><b>Perinatal death</b></p> <p>One trial investigated the effect of progestogens on neonatal death (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>) and two trials investigated the effect of progestogens on stillbirth (<a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>). </p> </section> <section id="CD005943-sec-0070"> <p><b>Congenital abnormalities</b></p> <p>Two trials (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>) reported congenital abnormalities as an outcome. </p> </section> <section id="CD005943-sec-0071"> <p><b>Intrauterine growth restriction and low birthweight</b></p> <p>Two trials (<a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>, <a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>) reported on the frequency of intrauterine growth restriction in the intervention and control groups. Another trial (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>) reported on the frequency of low birthweight in the progesterone and the placebo group. </p> </section> <section id="CD005943-sec-0072"> <p><b>Respiratory distress syndrome</b></p> <p>One trial (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>) investigated the rate of respiratory distress syndrome in the progesterone and the placebo group. </p> </section> <section id="CD005943-sec-0073"> <p><b>Birthweight</b></p> <p>Only one trial (<a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>) reported the difference in birthweight as an outcome. </p> </section> </section> </section> <section id="CD005943-sec-0074"> <h5 class="title">Date of trials</h5> <p>Six trials were published between 2004 and 2017 (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>). One trial was published in 1987 (<a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>). </p> </section> <section id="CD005943-sec-0075"> <h5 class="title">Funding source</h5> <p>Solvay Pharmaceuticals funded two trials (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>). The rest of the trials did not mention the source of funding. </p> </section> <section id="CD005943-sec-0076"> <h5 class="title">Delcaration of interest</h5> <p>None of the study authors reported any conflict of interest.</p> <p>For further details, see <a href="./references#CD005943-sec-0125" title="">Characteristics of included studies</a>. </p> </section> </section> <section id="CD005943-sec-0077"> <h4 class="title">Excluded studies</h4> <p>In this update of the review, we excluded 10 (plus two duplicate) full‐text trials, in addition to the 32 excluded from the previous version. The reasons for exclusion of the 42 trials was as follows: 18 trials had a different population to this review' criteria (<a href="./references#CD005943-bbs2-0012" title="BrennerWE , HendricksCH . Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation and labor. American Journal of Obstetrics and Gynecology1962;83:1094‐8. ">Brenner 1962</a>; <a href="./references#CD005943-bbs2-0015" title="CorradoF , DugoC , CannataML , DiBartoloM , ScilipotiA , StellaNC . A randomised trial of progesterone prophylaxis after midtrimester amniocentesis. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2002;100:196‐8. ">Corrado 2002</a>; <a href="./references#CD005943-bbs2-0019" title="ElZibdehMY . Randomized study comparing the efficacy of reducing spontaneous abortion following treatment with progesterone and human chorionic gonadotropin (hCG). Fertility and Sterility2000;70(3 Suppl 1):S77‐S78. ">El Zibdeh 2000</a>; <a href="./references#CD005943-bbs2-0020" title="ElZibdehM . Randomized clinical trial comparing the efficacy of dydrogesterone and human chorionic gonadotropin [abstract]. 10th World Congress on Menopause; 2002 July 10‐14; Berlin, Germany. 2002:136. ">El Zibdeh 2002</a>; <a href="./references#CD005943-bbs2-0021" title="El‐ZibdehMY . Dydrogesterone in the reduction of recurrent spontaneous abortion. Journal of Steroid Biochemistry &amp; Molecular Biology2005;97(5):431‐4. ">El Zibdeh 2005</a>; <a href="./references#CD005943-bbs2-0023" title="FuchsF , OlsenP . An attempted double‐blind controlled trial of progesterone therapy in habitual abortion. Ugeskrift for Laeger1966;128:1461‐2. ">Fuchs 1966</a>; <a href="./references#CD005943-bbs2-0024" title="GoldzieherJW . Double‐blind trial of a progestin in habitual abortion. JAMA1964;188(7):651‐4. ">Goldzieher 1964</a>; <a href="./references#CD005943-bbs2-0027" title="JohnsonJWC , AustinKL , JonesGS , DavisGH , KingTM . Efficacy of 17alpha‐hydroxyprogesterone caproate in the prevention of premature labor. New England Journal of Medicine1975;293:675‐80. ">Johnson 1975</a>; <a href="./references#CD005943-bbs2-0028" title="KlopperAI , MacNaughtonMC . Hormones in recurrent abortion. Journal of Obstetrics and Gynaecology of the British Commonwealth1965;72:1022‐8. ">Klopper 1965</a>; <a href="./references#CD005943-bbs2-0029" title="LeVineL . Habitual abortion. A controlled clinical study of progestational therapy. Western Journal of Surgery1964;72:30‐6. ">Le Vine 1964</a>; <a href="./references#CD005943-bbs2-0032" title="Nyboe AndersenA , Popovic‐TodorovicB , SchmidtKT , LoftA , LindhardA , HojgaardA , et al. Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Human Reproduction2002;17(2):357‐61. ">Nyboe 2002</a>; <a href="./references#CD005943-bbs2-0034" title="PorcaroG , BrilloE , GiardinaI , DiIorioR . Alpha lipoic acid (ALA) effects on subchorionic hematoma: preliminary clinical results. European Review for Medical and Pharmacological Sciences2015;19(18):3426‐32. ">Porcaro 2015</a>; <a href="./references#CD005943-bbs2-0035" title="PrietlG , DiedrichK , Van derVenHH , LuckhausJ , KrebsD . The effect of 17alpha‐hydroxyprogesterone caproate/oestradiol valerate on the development and outcome of early pregnancies following in vitro fertilization and embryo transfer: a prospective and randomized controlled trial. Human Reproduction1992;7(1):1‐5. ">Prietl 1992</a>; <a href="./references#CD005943-bbs2-0037" title="ReijndersFJL , ThomasCMG , DoesburgWH , RollandR , EskesTKAB . Endocrine effects of 17 alpha‐hydroxyprogesterone caproate during early pregnancy: a double‐blind clinical trial. British Journal of Obstetrics and Gynaecology1988;95:462‐8. ">Reijnders 1988</a>; <a href="./references#CD005943-bbs2-0038" title="ShearmanRP , GarrettWJ . Double‐blind study of effect of 17‐hydroxyprogesterone caproate on abortion rate. BMJ1963;1:292‐5. ">Shearman 1963</a>; <a href="./references#CD005943-bbs2-0041" title="SmitzJ , DevroeyP , FaguerB , BourgainC , CamusM , VanSteirteghemAC . Randomized prospective trial comparing supplementation of the luteal phase and of early pregnancy by natural progesterone given by intramuscular or vaginal administration. Revue Francaise de Gynecologie et d Obstetrique1992;87:507‐16. ">Smitz 1992</a>; <a href="./references#CD005943-bbs2-0045" title="SwyerGIM , DaleyD . Progesterone implantation in habitual abortion. British Medical Journal1953;1:1073‐86. ">Swyer 1953</a>; <a href="./references#CD005943-bbs2-0047" title="TurnerSJ , MizockGB , FeldmanGL . Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy. American Journal of Obstetrics and Gynecology1966;95:222‐7. ">Turner 1966</a>); 14 trials, either compared progesterone to another type of progesterone or used it in combination with another therapy (<a href="./references#CD005943-bbs2-0009" title="BeigiA , EsmailzadehA , PirjaniR . Comparison of risk of preterm labor between vaginal progesterone and 17‐alpha‐hydroxy‐progesterone caproate in women with threatened abortion: a randomized clinical trial. International Journal of Fertility &amp; Sterility2016;10(2):162‐8. [IRCT2014123120504N1] ">Beigi 2016</a>; <a href="./references#CD005943-bbs2-0010" title="BerleP , BehnkeK . The treatment of threatened abortion. Geburtshilfe und Frauenheilkunde1977;37:139‐42. ">Berle 1977</a>; <a href="./references#CD005943-bbs2-0013" title="CheckJH , TarquiniP , GandyP , LauerC . A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment vs progesterone alone in primary habitual aborters. Gynecologic and Obstetric Investigation1995;39:257‐61. ">Check 1995</a>; <a href="./references#CD005943-bbs2-0014" title="ChyeTT , ChiCTR‐IOR‐17011593 . The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage. chictr.org.cn/showproj.aspx?proj=19668 (first received 6 July 2017). ChyeTT , ChiCTR‐IPR‐14005251 . Micronised progesterone versus dydrogesterone: a randomised controlled trial. chictr.org.cn/showproj.aspx?proj=9539http://www.chictr.org.cn/showproj.aspx?proj=9539 (first received 21 September 2014). ">Chye 2014</a> (and duplicate); <a href="./references#CD005943-bbs2-0018" title="CzajkowskiK , SienkoJ , MogilinskiM , BrosM , SzczecinaR , CzajkowskaA . Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone. Fertility and Sterility2007;87(3):613‐8. ">Czajkowski 2007</a>; <a href="./references#CD005943-bbs2-0022" title="FaminaM . The effect of dydrogesterone on placental angiogenesis and pregnancy outcomes in women with threatened miscarriages. Giornale Italiano di Ostetricia e Ginecologia2015;37(4):155‐8. ">Famina 2015</a>; <a href="./references#CD005943-bbs2-0026" title="HuiCYY , SiewSJY , TanTC . Biochemical and clinical outcomes following the use of micronised progesterone and dydrogesterone for threatened miscarriage ‐ a randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):276. ">Hui 2015</a>; <a href="./references#CD005943-bbs2-0030" title="LuzNP . Hormones in the treatment of patients with threatened early pregnancy loss. Letter to: Oxford Database of Perinatal Trials, John Radcliffe Infirmary, Oxford 22 October 1988. ">Luz 1988 [pers comm]</a>; <a href="./references#CD005943-bbs2-0036" title="PustotinaOA . Effectiveness of dydrogesterone, 17‐OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix. Journal of Maternal‐Fetal &amp; Neonatal Medicine2018;31(14):1830‐8. ">Pustotina 2018</a>; <a href="./references#CD005943-bbs2-0039" title="SiewJYS , AllenJC , MalhotraR , OstbyeT , HeS , TanTC . Progesterone for threatened miscarriage: a randomised controlled trial comparing micronised progesterone and dydrogesterone. Journal of Maternal‐Fetal &amp; Neonatal Medicine2014;27(Suppl 1):243. ">Siew 2014</a>; <a href="./references#CD005943-bbs2-0040" title="SiewS , HuiCYY , TanTC , AllenJC , MalhotraR . Micronized progesterone compared with dydrogesterone for threatened miscarriage: a randomized controlled trial. Obstetrics &amp; Gynecology2015;125(5 Suppl):104S. ">Siew 2015</a>; <a href="./references#CD005943-bbs2-0043" title="SongYL , ZhuLP . The fetus protection effects of Zhixue Baotai Decoction on women of early threatened abortion with dark area surrounding pregnancy sac. Chinese Journal of Integrated Traditional and Western Medicine2007;27(11):1025‐8. ">Song 2007</a>; <a href="./references#CD005943-bbs2-0048" title="VinczeE , MolnarGB , FoldesiI , PalA . Treatment possibilities using progestagens and progesteron‐like preparations in threatened abortion [A fenyegeto veteles kezelesenek lehetosegei progeszteron es progeszteron‐szeru keszitmenyekkel]. Magyar Noorvosok Lapja2006;69(4):281‐4. ">Vincze 2006</a>; <a href="./references#CD005943-bbs2-0049" title="ZhangJ , ZhangY , LiuG . Clinical and experimental study on yun'an granule in treating threatened abortion. Chung‐Kuo Chung Hsi i Chieh Ho Tsa Chih2000;20(4):251‐4. ">Zhang 2000</a>); seven trials did not use a reliable method to confirm the viability of the fetus (<a href="./references#CD005943-bbs2-0011" title="BerleP , BudenzM , MichaelisJ . Is hormonal therapy still justified in imminent abortion. Zeitschrift fur Geburtshilfe und Perinatologie1980;184:353‐8. ">Berle 1980</a>; <a href="./references#CD005943-bbs2-0017" title="CrowderRE , BillsES , BroadbentJS . The management of threatened abortion: a study of 100 cases. American Journal of Obstetrics and Gynecology1950;60:896‐9. ">Crowder 1950</a>; <a href="./references#CD005943-bbs2-0025" title="Govaerts‐VidetzkyM , MartinL , HubinontPO . A double‐blind study of progestogen treatment in spontaneous abortion (preliminary report). Journal of Obstetrics and Gynaecology of the British Commonwealth1965;72:1034. ">Govaerts‐Videtzky 1965</a>; <a href="./references#CD005943-bbs2-0031" title="MollerKJA , FuchsF . Double blind controlled trial of 6‐methyl‐17‐acetoxyprogesterone in threatened abortion. Journal of Obstetrics and Gynaecology of the British Commonwealth1965;72:1042‐4. ">Moller 1965</a>; <a href="./references#CD005943-bbs2-0042" title="SondergaardF , OttesenB , DetlefsenGU , SchierupL , PedersonSC , LebechPE . Progesterone treatment of cases of threatened pre‐term delivery in women with a low level of plasma progesterone. Contraception Fertilite Sexualite1985;13:1227‐31. ">Sondergaard 1985</a>; <a href="./references#CD005943-bbs2-0044" title="SoukaAR , OsmanM , SibaieF , EinenMA . Therapeutic value of indomethacin in threatened abortion. Prostaglandins1980;19:457‐60. ">Souka 1980</a>; <a href="./references#CD005943-bbs2-0046" title="TognoniG , FerrarioL , InzalacoM , CrosignaniPG . Progestagens in threatened abortion. Lancet1980;2:1242‐3. ">Tognoni 1980</a>); one study (and duplicate) had a mixed group of participants and we could not obtain separate results for the threatened‐miscarriage group (<a href="./references#CD005943-bbs2-0016" title="CostantinoD , NCT02601898 . Vaginal administration of alpha lipoic acid vs progesterone for the subchorionic hematoma treatment. clinicaltrials.gov/show/NCT02601898 (first received 6 November 2015). CostantinoM , GuaraldiC , CostantinoD . Resolution of subchorionic hematoma and symptoms of threatened miscarriage using vaginal alpha lipoic acid or progesterone: clinical evidences. European Review for Medical and Pharmacological Sciences2016;20(8):1656‐63. ">Costantino 2016</a>); one was not an RCT (<a href="./references#CD005943-bbs2-0008" title="AkhtarM , FatimaN , JabeenS , AkramM . Role of progesterone in the management of threatened miscarriage. Pakistan Journal of Medical and Health Sciences2012;6(1):261‐4. ">Akhtar 2012</a>); and one study had a high rate of attrition, more than 20% (<a href="./references#CD005943-bbs2-0033" title="OmarMH , MashitaMK , LimPS , JamilMA . Dydrogesterone in threatened abortion: pregnancy outcome. Journal of Steroid Biochemistry &amp; Molecular Biology2005;97(5):421‐5. ">Omar 2005</a>). </p> <p>For further details, see <a href="./references#CD005943-sec-0126" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD005943-sec-0078"> <h3 class="title">Risk of bias in included studies</h3> <p>(<a href="#CD005943-fig-0002">Figure 2</a>, <a href="#CD005943-fig-0003">Figure 3</a>) </p> <div class="figure" id="CD005943-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial" data-id="CD005943-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial </p> </div> </div> </div> <div class="figure" id="CD005943-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials" data-id="CD005943-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials </p> </div> </div> </div> <p>We judged only three of the seven included trials (42%) to be at low risk of bias for random sequence generation and allocation concealment, and four trials (57%) to be at low risk for performance bias. We judged all trials (100%) at low risk of detection bias and attrition bias. We judged six trials at low risk of selective reporting bias (85%), and five trials (71%) at low risk of other biases. </p> <section id="CD005943-sec-0079"> <h4 class="title">Allocation</h4> <p>In three trials (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>), the investigators described a random component in the sequence‐generation process by using computer random‐number generators, so we judged these trials to have low risk of selection bias. In three trials (<a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>), there was insufficient information about the sequence‐generation process to permit judgement of low or high risk, so we judged them as unclear risk of selection bias. We judged one study (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>) as high risk for selection bias, as the investigators described a non‐random component in the sequence‐generation process, which was based on the day of the week that women presented to the clinic. </p> <p>Participants and investigators enrolling participants could not foresee assignment to intervention or control group in three trials because <a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a> and <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a> used sequentially numbered drug containers of identical appearance and <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a> used sequentially numbered concealed envelopes; we judged these trials at low risk of selection bias. Three trials (<a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>), did not describe the method of concealment sufficiently to allow a definite judgement, so we judged them at unclear risk of selection bias. In <a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>, participants and investigators enrolling participants could foresee assignments, as the allocation was performed by the attending physician based on the day of the week the women visited the clinic, and thus the risk of selection bias introduction was high. </p> </section> <section id="CD005943-sec-0080"> <h4 class="title">Blinding</h4> <p>Four trials (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>) ensured blinding of participants and key study personnel, and it is unlikely that the blinding could have been broken, so we judged the risk of performance bias to be low. Three trials did not use placebo for the control group. Two of these (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>) did not blind either personnel or women to the treatment received and one (<a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>) was a single‐blind study, in which the researchers were unaware which woman had received progesterone. Although outcomes such as miscarriage, preterm birth and fetal structural malformations are not likely to be influenced by lack of blinding, lack of blinding of participants or personnel could have introduced performance bias if participants inadvertently took a different type of progestogen than the one in the trial or exaggerated their reports of subjective outcomes, such as pain. </p> <p>Five of the seven trials blinded outcome assessors to the treatment the women had received (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>). <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a> did not blind the assessors, and <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a> did not give any information about blinding. Outcomes such as miscarriage, preterm birth and fetal structural malformations are not likely to be influenced by lack of assessor's blinding, so we judged all seven trials as having low risk of detection bias. </p> </section> <section id="CD005943-sec-0081"> <h4 class="title">Incomplete outcome data</h4> <p>There was no missing outcome data in five of the seven included trials (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013;</a><a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>); <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a> excluded two women (5.7%) from the study after randomisation, and <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a> reported incomplete outcome data for 12 women (14.5%), equal in both groups. We judged all seven trials to be at low risk of attrition bias. </p> </section> <section id="CD005943-sec-0082"> <h4 class="title">Selective reporting</h4> <p>All the included trials, except one (<a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>), reported all of the expected prespecified (primary and secondary) outcomes, so we assessed these at low risk of reporting bias. In <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>, the study authors mentioned in the methods that they would report all the adverse effects, but in the results there was no explicit mention of the absence or presence of any adverse effects, so we judged it to be at high risk of reporting bias. </p> </section> <section id="CD005943-sec-0083"> <h4 class="title">Other potential sources of bias</h4> <p>We assessed one study at high risk of other biases due to the difference in the number of participants recruited to the experimental and the control groups (86 versus 60; <a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>). In another study (<a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>), the risk of other bias was not clear because we included only participants with evidence of fetal viability, which amounts to only half of the participants. </p> </section> </section> <section id="CD005943-sec-0084"> <h3 class="title" id="CD005943-sec-0084">Effects of interventions</h3> <p>See: <a href="./full#CD005943-tbl-0001"><b>Summary of findings for the main comparison</b> Progesterone compared to placebo or no treatment for treating threatened miscarriage</a> </p> <p>Seven trials met the inclusion criteria, involving 696 participants. We performed subgroup analysis for the effect of progestogens by route of administration; however, due to paucity of data we could not carry out subgroup analysis for type and dose of progestogen. We undertook a total of six meta‐analyses. </p> <section id="CD005943-sec-0085"> <h4 class="title">Primary outcome</h4> <section id="CD005943-sec-0086"> <h5 class="title">Miscarriage</h5> <p>The seven included trials, with 696 participants, compared progestogens to either placebo (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>: <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>) or no treatment (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>). Treatment of miscarriage with progestogens compared to placebo or no treatment probably reduces the risk of miscarriage; (risk ratio (RR) 0.64, 95% confidence interval (CI) 0.47 to 0.87; 7 trials; 696 women; moderate‐quality evidence). </p> <section id="CD005943-sec-0087"> <h6 class="title">Subgroup analysis by route of administration</h6> <p>Three trials investigated treatment with oral progestogen (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>), and showed that treatment with oral progestogen compared to no treatment probably reduces the miscarriage rate (RR 0.57, 95% CI 0.38 to 0.85; 3 trials; 408 women; moderate‐quality evidence; <a href="./references#CD005943-fig-0004" title="">Analysis 1.1</a>.1). Four trials investigated treatment with vaginal progesterone compared to placebo (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>), which probably has little or no effect in reducing the miscarriage rate (RR 0.75, 95% CI 0.47 to 1.21; 4 trials; 288 women; moderate‐quality evidence; <a href="./references#CD005943-fig-0004" title="">Analysis 1.1</a>.2). However, It should be noted that there were no differences between these two subgroups according to the subgroup interaction test (test for subgroup differences: Chi² = 0.76, df = 1 (P = 0.38), I² = 0%). </p> </section> </section> </section> <section id="CD005943-sec-0088"> <h4 class="title">Secondary outcomes</h4> <section id="CD005943-sec-0089"> <h5 class="title">Maternal outcomes</h5> <section id="CD005943-sec-0090"> <h6 class="title">Pain relief</h6> <p>Two trials (<a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>) reported pain relief as an outcome of treatment with progesterone. <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a> reported reduction on the mean pain score with the use of progesterone from 2.6 ± 0.9 before treatment to 0.4 ± 0.7 (mean ± standard deviation) after treatment (P &lt; 0.01), while no change in pain score was observed in women who received placebo from 2.5 ± 1.0 before treatment to 2.4 ± 0.8 (mean ± standard deviation) after treatment (P &gt; 0.05). They reported pain using a progressive score from 0 to 4, where a score of 0 indicated 'no pain' and a score of 4 indicated 'extreme pain'. In <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>, nine (30%) of the women in the progesterone and seven (23.3%) of the control group, continued to have pain after intervention (P = 0.55). We could not pool the results of these two trials due to the different types of data (dichotomous and continuous). </p> </section> <section id="CD005943-sec-0091"> <h6 class="title">Preterm birth</h6> <p>Five trials (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>, <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>); reported the effect of progestogens on preterm birth. Treatment of preterm birth with the use of progestogens compared to placebo or no treatment may have little or no effect in reducing the rate of preterm birth (RR 0.86, 95% CI 0.52 to 1.44; 5 trials; 588 women; low‐quality evidence; <a href="./references#CD005943-fig-0005" title="">Analysis 1.2</a>). </p> </section> </section> <section id="CD005943-sec-0092"> <h5 class="title">Other maternal adverse outcomes</h5> <section id="CD005943-sec-0093"> <h6 class="title">Pregnancy‐induced hypertension</h6> <p>Two trials (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>) reported pregnancy‐induced hypertension as a maternal adverse outcome. There was no difference in the occurrence of pregnancy‐induced hypertension between the progestogen and the control group (RR 1.00, 95% CI 0.54 to 1.88; 2 trials; 337 women; <a href="./references#CD005943-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD005943-sec-0094"> <h6 class="title">Antepartum haemorrhage</h6> <p>Two trials (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>) reported antepartum haemorrhage as maternal adverse outcome. Progestogens have little or no difference in the occurrence of antepartum haemorrhage (RR 0.76, 95% CI 0.30 to 1.94; 2 trials; 337 women; <a href="./references#CD005943-fig-0007" title="">Analysis 1.4</a>). </p> </section> </section> <section id="CD005943-sec-0095"> <h5 class="title">Child outcomes</h5> <section id="CD005943-sec-0096"> <h6 class="title">Stillbirth</h6> <p>Two trials investigated the effect of progestogens on the stillbirth rate (<a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>). Progestogens have little or no difference effects on the rate of stillbirth (RR 1.94, 95% CI 0.18 to 20.49; 2 trials; 262 women; <a href="./references#CD005943-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD005943-sec-0097"> <h6 class="title">Congenital abnormalities</h6> <p>Two trials (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>) reported congenital abnormalities as an outcome. We are uncertain if treatment of threatened miscarriage with progestogens compared to placebo or no treatment has any effect on the rate of congenital abnormalities, (RR 0.70, 95% CI 0.10 to 4.82; 2 trials; 337 infants; very low‐quality evidence; <a href="./references#CD005943-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD005943-sec-0098"> <h6 class="title">Neonatal death</h6> <p>Only one trial reported the effect of progestogens on neonatal death (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>). Progestogens have little or no effect in the neonatal death rate (RR 1.35, 95% CI 0.31 to 5.83; 1 trial; 145 women). </p> <p><b>Other neonatal adverse outcomes</b> </p> </section> <section id="CD005943-sec-0099"> <h6 class="title">Intrauterine growth restriction and low birthweight</h6> <p>One trial (<a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>) reported on the frequency of intrauterine growth restriction in the intervention and control group and showed no difference between the two groups; 0 (0%) in the progestogen group, one (3.5%) in the control group. Another trial (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>) reported on the frequency of low birthweight in the progesterone and the placebo group and showed no difference between the two groups; five (7%) for the progesterone group and seven (9.8%) for the placebo group. </p> </section> <section id="CD005943-sec-0100"> <h6 class="title">Birthweight</h6> <p>Only one trial (<a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>) reported the difference in birthweight as an outcome. It showed no difference in the mean birthweight between the progestogen and the control group; 3.1156 ± 0.643 kg for the intervention group and 3.2076 ± 0.500 kg for the control group. </p> </section> <section id="CD005943-sec-0101"> <h6 class="title">Respiratory distress syndrome</h6> <p>One trial (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>) investigated the rate of respiratory distress syndrome in the progesterone and the placebo groups, and showed no difference between the two groups; there were two neonates with respiratory distress syndrome (2.8%) in the progesterone group and one (1.4%) in the placebo group. </p> </section> </section> </section> <section id="CD005943-sec-0102"> <h4 class="title">Outcomes not reported in the primary trials</h4> <p>Due to paucity of data, we could not evaluate the following secondary outcomes.</p> <p> <ol id="CD005943-list-0014"> <li> <p>Thromboembolism</p> </li> <li> <p>Depression</p> </li> </ol> </p> <p>In addition we could not perform the following subgroup analyses.</p> <p> <ol id="CD005943-list-0015"> <li> <p>Route of progestogen administration</p> </li> <li> <p>Type of progestogen</p> </li> <li> <p>Progestogen dose</p> </li> <li> <p>Effect of progestogens in early and late miscarriage</p> </li> </ol> </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005943-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005943-sec-0103"></div> <section id="CD005943-sec-0104"> <h3 class="title" id="CD005943-sec-0104">Summary of main results</h3> <p>We included seven trials (involving 696 participants) in this update of the review. The included trials were conducted in different countries, covering the full spectrum of the World Bank's economic classification (<a href="./references#CD005943-bbs2-0111" title="WorldBank . World Bank list of economies. iccmoot.com/wp‐content/uploads/2017/07/World‐Bank‐List‐of‐Economies.pdf. ">World Bank 2017</a>), which enhances the applicability of evidence drawn from this review. Two trials were conducted in Germany and Italy which are high‐income countries, while four trials were conducted in upper‐middle income countries; two in Iran, one in Malaysia and the fourth in Turkey, and the seventh trial was conducted in Jordon, which is a lower‐middle income country. In six trials all the participants met the inclusion criteria and in the seventh study, we included only the subgroup of participants who met the inclusion criteria in the meta‐analysis. Using the GRADE tool, we assessed the body of evidence for the main outcomes as ranging from very low‐quality to moderate‐quality evidence. Downgrading of evidence was based on the high risk of bias in six of the seven included trials and imprecision for some of the outcomes. </p> <p>Treatment of miscarriage with progestogens compared to placebo or no treatment probably reduces the risk of miscarriage. Subgroup analysis by route of administration showed that treatment with oral progestogen compared to no treatment probably reduces the miscarriage rate, although treatment with vaginal progesterone compared to placebo, probably has little or no effect in reducing the miscarriage rate. However, the subgroup interaction test indicated no difference according to route of administration between the oral and vaginal subgroups of progesterone. Treatment of preterm birth with the use of progestogens compared to placebo or no treatment may have little or no effect in reducing the rate of preterm birth. We are uncertain if treatment of threatened miscarriage with progestogens compared to placebo or no treatment has any effect on the rate of congenital abnormalities. </p> </section> <section id="CD005943-sec-0105"> <h3 class="title" id="CD005943-sec-0105">Overall completeness and applicability of evidence</h3> <p>Threatened miscarriage is a common health problem. In a longitudinal study by <a href="./references#CD005943-bbs2-0062" title="BlohmF , FridenB , MilsomI . A prospective longitudinal population‐based study of clinical miscarriage in an urban Swedish population. BJOG: an international journal of obstetrics and gynaecology2008;115:176‐82. ">Blohm 2008</a>, one in four multiparous women had experienced a miscarriage and more than 7% of the studied population had experienced three or more miscarriages. In a large population‐based study by <a href="./references#CD005943-bbs2-0065" title="CohainJS , BuxbaumRE , MankutaD . Spontaneous first trimester miscarriage rates per woman among parous women with 1 or more pregnancies of 24 weeks or more. BMC Pregnancy and Childbirth2017;17(1):437. ">Cohain 2017</a>, more than 40% of parous women reported having experienced one or more first trimester spontaneous miscarriages. </p> <p>This update of the review includes seven trials, with a relatively small number of women (696), from six countries. All trials were conducted in hospital settings. Two trials were conducted in high‐income countries (<a href="./references#CD005943-bbs2-0003" title="GerhardI , GwinnerB , Eggert‐KruseW , RunnebaumB . Double‐blind controlled trial of progesterone substitution in threatened abortion. Biological Research in Pregnancy and Perinatology1987;8:26‐34. ">Gerhard 1987</a>; <a href="./references#CD005943-bbs2-0004" title="PalagianoA , BullettiC , PaceMC , DeZieglerD , CicinelliE , IzzoA . Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Annals of the New York Academy of Sciences2004;1034:200‐10. ">Palagiano 2004</a>), four in upper‐middle income countries (<a href="./references#CD005943-bbs2-0001" title="AlimohamadiS , JavadianP , GharedaghiMH , JavadianN , AliniaH , KhazardoustS , et al. Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations. Journal of Reproductive Immunology2013;98(1‐2):52‐60. ">Alimohamadi 2013</a>; <a href="./references#CD005943-bbs2-0005" title="PandianRU . Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas2009;65 Suppl 1:S47‐S50. ">Pandian 2009</a>; <a href="./references#CD005943-bbs2-0006" title="TurgalM , AydinE , OzyuncuO . Effect of micronized progesterone on fetal‐placental volume in first‐trimester threatened abortion. Journal of Clinical Ultrasound2017;45(1):14‐9. ">Turgal 2017</a>; <a href="./references#CD005943-bbs2-0007" title="YassaeeF , Shekarriz‐FoumaniR , AfsariS , FallahianM . The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. Journal of Reproduction &amp; Infertility2014;15(3):147‐51. ">Yassaee 2014</a>) and one in lower‐middle income country (<a href="./references#CD005943-bbs2-0002" title="El‐ZibdehMY , YousefLT . Dydrogesterone support in threatened miscarriage. Maturitas2009;65 Suppl 1:S43‐S46. ">El‐Zibdeh 2009</a>). Although no trial was conducted in a low‐income country, the participants in the trials of the review have diverse ethnic and economic backgrounds (<a href="./references#CD005943-bbs2-0111" title="WorldBank . World Bank list of economies. iccmoot.com/wp‐content/uploads/2017/07/World‐Bank‐List‐of‐Economies.pdf. ">World Bank 2017</a>). This may make the evidence in this review applicable to a large sector of women with threatened miscarriage. </p> </section> <section id="CD005943-sec-0106"> <h3 class="title" id="CD005943-sec-0106">Quality of the evidence</h3> <p>In this updated review we assessed the body of evidence for miscarriage as moderate quality, mainly due to limitations in study design of the included trials. From the seven included trials we judged only three (42%) to be at low risk of bias for random sequence generation and allocation concealment. Four trials (57%) were at low risk for performance bias, and all were at low risk of detection bias. We assessed all trials at low risk for attrition bias and six were at low risk of selective reporting bias. Only five trials (71%) trials were at low risk for other biases (<a href="./full#CD005943-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>For preterm birth we assessed the body of evidence as low quality due to imprecision (wide confidence intervals crossing the no‐effect line) and limitations with study design of the included trials. From the five included trials, three (60%) were at low risk of bias for random sequence generation, while three (60%) were at low risk of performance bias and all trials were at low risk of detection bias. In addition, one study randomised different numbers of participants to the two arms of the study, which we considered as additional bias and in one study we included the results of only 50% of the participants who met the inclusion criteria. </p> <p>For the outcome congenital abnormality, we assessed the body of evidence as very low due to imprecision (wide confidence intervals crossing the no‐effect line), small number of trials (two trials) and participants (337 women) and limitations with study design. We assessed one of the two included trials to be at high risk of selection bias and performance bias and the other study at high risk of performance bias. </p> </section> <section id="CD005943-sec-0107"> <h3 class="title" id="CD005943-sec-0107">Potential biases in the review process</h3> <p>In this review, we took steps to minimise bias, although we are aware that bias may be present in our review: two review authors independently assessed trials for eligibility and extracted the data as necessary. We resolved discrepancies through discussion or, if required, we consulted a third review author; two review authors also performed GRADE assessments independently and resolved discrepancies though discussion; and we conducted a comprehensive search in order to identify all relevant published and unpublished literature. </p> </section> <section id="CD005943-sec-0108"> <h3 class="title" id="CD005943-sec-0108">Agreements and disagreements with other studies or reviews</h3> <p>Our assessment of the body of evidence in this update of the review did not differ much from the previous version of the review (<a href="./references#CD005943-bbs2-0113" title="WahabiHA , FayedAA , EsmaeilSA , Al ZeidanRA . Progestogen for treating threatened miscarriage. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD005943.pub4] ">Wahabi 2011</a>). For the main comparison, we have included three additional trials, however, neither the magnitude nor the direction of evidence changed markedly from the earlier version of the review. We have used the recent methodology introduced for Cochrane Reviews in 2008, which assesses risk of bias in the individual trials more carefully than in the past (<a href="./references#CD005943-bbs2-0083" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). In addition, we assessed the quality of the evidence using the GRADE approach as outlined in the GRADE Handbook (<a href="./references#CD005943-bbs2-0076" title="Editors: SchünemannH , BrożekJ , GuyattG , OxmanA . Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html. ">GRADE 2013</a>). </p> <p>The results of this review agree with a recently published systematic review of randomised and non‐randomised controlled trials of dydrogesterone (oral progestogen) for the treatment of threatened miscarriage (<a href="./references#CD005943-bbs2-0063" title="CarpH . A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecological Endocrinology2012;28(12):983‐90. ">Carp 2012</a>) and with non‐randomised controlled trials (<a href="./references#CD005943-bbs2-0008" title="AkhtarM , FatimaN , JabeenS , AkramM . Role of progesterone in the management of threatened miscarriage. Pakistan Journal of Medical and Health Sciences2012;6(1):261‐4. ">Akhtar 2012</a>), which investigated the effectiveness of oral progestogens in the treatment of threatened miscarriage. The results of this trial showed that a larger proportion of women who received progestogen continued to be pregnant compared to the control group, however, the difference was not significant. </p> <p>Recently published trials suggested that the route of administration and the type of progestogen influence its effectiveness in the prevention of miscarriage. In a multicenter, randomised, placebo‐controlled trial on women with unexplained recurrent miscarriages, vaginal progesterone was found not to be significantly different from placebo in the prevention of miscarriage (<a href="./references#CD005943-bbs2-0066" title="CoomarasamyA , WilliamsH , TruchanowiczE , SeedPT , SmallR , QuenbyS , et al. A randomized trial of progesterone in women with recurrent miscarriages. New England Journal of Medicine2015;373(22):2141‐8. ">Coomarasamy 2015</a>). However, the results of a review of randomised trials on the use of progestogen in the prevention of recurrent miscarriage, concluded that synthetic progestogens, but not natural progesterone, were associated with a lower risk of recurrent miscarriage, nevertheless, the conclusion was limited by the low quality of evidence (<a href="./references#CD005943-bbs2-0100" title="SacconeG , SchoenC , FranasiakJM , ScottRTJr , BerghellaV . Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta‐analysis of randomized, controlled trials. Fertility and Sterility2017;107(2):430‐8. ">Saccone 2017</a>). </p> <p>Our results suggested that progestogen may not be as effective in the prevention of preterm birth (<a href="./references#CD005943-fig-0005" title="">Analysis 1.2</a>). There are conflicting published reports about the effectiveness of progestational agents in the prevention of preterm birth with apparent influence of type of progestogen and route of administration, as well as different subgroups of women, on the effectiveness of treatment (<a href="./references#CD005943-bbs2-0074" title="FacchinettiF , VerganiP , DiTommasoM , MarozioL , AcaiaB , ViciniR , et al. Progestogens for maintenance tocolysis in women with a short cervix: a randomized controlled trial. Obstetrics and Gynecology2017;130(1):64‐70. ">Facchinetti 2017</a>; <a href="./references#CD005943-bbs2-0080" title="HeyborneKD . 17‐α hydroxyprogesterone caproate for the prevention of recurrent preterm birth: one size may not fit all. Obstetrics &amp; Gynecology2016;128(4):899‐90. ">Heyborne 2016</a>; <a href="./references#CD005943-bbs2-0093" title="O'BrienJM , LewisDF . Prevention of preterm birth with vaginal progesterone or 17‐alpha‐hydroxyprogesterone caproate: a critical examination of efficacy and safety. American Journal of Obstetrics and Gynecology2016;214(1):45‐56. ">O'Brien 2016</a>). </p> <p>Our results relating to the safety of progestogen use for the mother and infant are limited by the small number of trials and participants in addition to the low quality of the evidence. However, our systematic review is in agreement with other systematic reviews, which also suggest that there are no increased risks of adverse outcomes to the mother or the infant from the use of progestogen compared to the control group (<a href="./references#CD005943-bbs2-0078" title="HaasDM , HathawayTJ , RamseyPS . Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database of Systematic Reviews2018, Issue [in press]. ">Haas 2018</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005943-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/urn:x-wiley:14651858:media:CD005943:CD005943-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_t/tCD005943-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Trial flow diagram" data-id="CD005943-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Trial flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005943-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/urn:x-wiley:14651858:media:CD005943:CD005943-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_t/tCD005943-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial" data-id="CD005943-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005943-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/urn:x-wiley:14651858:media:CD005943:CD005943-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_t/tCD005943-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials" data-id="CD005943-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005943-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/urn:x-wiley:14651858:media:CD005943:CD005943-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_t/tCD005943-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Progestogens versus placebo or no treatment, Outcome 1 Miscarriage." data-id="CD005943-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Progestogens versus placebo or no treatment, Outcome 1 Miscarriage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/references#CD005943-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005943-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/urn:x-wiley:14651858:media:CD005943:CD005943-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_t/tCD005943-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Progestogens versus placebo or no treatment, Outcome 2 Preterm birth." data-id="CD005943-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Progestogens versus placebo or no treatment, Outcome 2 Preterm birth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/references#CD005943-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005943-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/urn:x-wiley:14651858:media:CD005943:CD005943-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_t/tCD005943-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Progestogens versus placebo or no treatment, Outcome 3 Pregnancy‐induced hypertension." data-id="CD005943-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Progestogens versus placebo or no treatment, Outcome 3 Pregnancy‐induced hypertension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/references#CD005943-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005943-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/urn:x-wiley:14651858:media:CD005943:CD005943-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_t/tCD005943-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Progestogens versus placebo or no treatment, Outcome 4 Antepartum haemorrhage." data-id="CD005943-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Progestogens versus placebo or no treatment, Outcome 4 Antepartum haemorrhage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/references#CD005943-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005943-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/urn:x-wiley:14651858:media:CD005943:CD005943-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_t/tCD005943-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Progestogens versus placebo or no treatment, Outcome 5 Stillbirth." data-id="CD005943-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Progestogens versus placebo or no treatment, Outcome 5 Stillbirth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/references#CD005943-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005943-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/urn:x-wiley:14651858:media:CD005943:CD005943-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_t/tCD005943-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Progestogens versus placebo or no treatment, Outcome 6 Congential abnormalities." data-id="CD005943-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Progestogens versus placebo or no treatment, Outcome 6 Congential abnormalities.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/references#CD005943-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/media/CDSR/CD005943/image_n/nCD005943-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005943-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Progesterone compared to placebo or no treatment for treating threatened miscarriage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Progesterone compared to placebo or no treatment for treating threatened miscarriage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population</b> : women with threatened miscarriage<br/> <b>Setting:</b> two in high‐income countries (Germany and Italy), four in upper‐middle income countries (two in Iran, one in Malaysia and one in Turkey) and one in lower‐income country (Jordan). All in hospitals (university or women's) or medical centres<br/> <b>Intervention:</b> progesterone<br/> <b>Comparison:</b> placebo or no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (trials)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with progesterone</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.64<br/> (0.47 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>696<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>242 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>138 per 1000<br/> (102 to 189) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Preterm birth</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.86<br/> (0.52 to 1.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>588<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>84 per 1000<br/> (49 to 142) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Congential abnormalities</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.70<br/> (0.10 to 4.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>337<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>1, 2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (1 to 62) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT</b> : randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Random sequence generation and/or allocation concealment had a high or unclear risk of bias in the majority of the trials (methodological quality of trials) (‐1).<br/> <sup>2</sup>Wide confidence interval crossing the no effect line (imprecision) (‐1).<br/> <sup>3</sup>A small number of events (‐1). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Progesterone compared to placebo or no treatment for treating threatened miscarriage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/full#CD005943-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005943-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Progestogens versus placebo or no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>696</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.47, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Oral progestogen versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>408</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.38, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Vaginal progesterone versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.47, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>588</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.52, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pregnancy‐induced hypertension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>337</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.54, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Antepartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>337</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.30, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Stillbirth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.94 [0.18, 20.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Congential abnormalities <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>337</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.10, 4.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Progestogens versus placebo or no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005943.pub5/references#CD005943-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005943.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005943-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005943-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD005943-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD005943-note-0001">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005943\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005943\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005943\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005943\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005943\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=gpg7sF9V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005943.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005943.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005943.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005943.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005943.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719519381"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005943.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719519384"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005943.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918deaba6a429373',t:'MTc0MDcxOTUxOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 